Discovery Laboratories (DSCO) and FDA Meet to Clarify Limited Items in SURFAXIN® Approvable Letter
Discovery Laboratories, Inc. (NASDAQ: DSCO), a biotechnology company developing Surfactant Replacement Therapies (SRT) for respiratory diseases, held a teleconference on…